TransMedics (TMDX) Change in Receivables (2018 - 2026)

TransMedics' Change in Receivables history runs 9 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 85.23% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at -$51.6 million (down 185.89% YoY), while the FY2025 annual figure was -$14.0 million, down 140.66% from the prior year.
• Change in Receivables was $6.5 million for Q1 2026 at TransMedics, up from $3.6 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $44.1 million in Q1 2025 to a low of -$37.5 million in Q2 2025.
• Historically, Change in Receivables has averaged $4.8 million across 5 years, with a median of $6.5 million in 2026.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables jumped 895.54% in 2022, then slumped 4856.14% in 2025.
• A 5-year view of Change in Receivables shows it stood at $5.4 million in 2022, then plunged by 47.71% to $2.8 million in 2023, then surged by 178.15% to $7.8 million in 2024, then plunged by 54.32% to $3.6 million in 2025, then surged by 82.02% to $6.5 million in 2026.
• The last three Change in Receivables figures came in at $6.5 million (Q1 2026), $3.6 million (Q4 2025), and -$24.1 million (Q3 2025), per Business Quant data.